|
|
|
|
|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from FORM 10Q FOR
THE PERIOD ENDED 9-30-2000 and is qualified in its entirety by reference to such
financial statements.
</LEGEND>
<CIK> 0001030418
<NAME> BIONX IMPLANTS, INC.
<MULTIPLIER> 1,000
<CURRENCY> US
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<EXCHANGE-RATE> 1
<CASH> 6,481
<SECURITIES> 0
<RECEIVABLES> 2,394
<ALLOWANCES> 387
<INVENTORY> 7,492
<CURRENT-ASSETS> 17,970
<PP&E> 2,206
<DEPRECIATION> 935
<TOTAL-ASSETS> 24,107
<CURRENT-LIABILITIES> 3,491
<BONDS> 0
0
0
<COMMON> 21
<OTHER-SE> 20,010
<TOTAL-LIABILITY-AND-EQUITY> 24,107
<SALES> 13,213
<TOTAL-REVENUES> 13,796
<CGS> 4,781
<TOTAL-COSTS> 15,661
<OTHER-EXPENSES> 410
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> (248)
<INCOME-PRETAX> (2,027)
<INCOME-TAX> 0
<INCOME-CONTINUING> (2,027)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (2,027)
<EPS-BASIC> (0.19)
<EPS-DILUTED> (0.19)
</TABLE>
|
|